Contact the Editorial Desk

Editorial correspondence

Southern Peptide Co welcomes correspondence on the research record: a citation quoted inaccurately, a newly published trial, a regulatory update that changes an approval or WADA-prohibited status, or a peer-reviewed study on GHK-Cu, TB-500, or BPC-157 that should be added to the references page. This class of correction is the most useful message this desk receives.

The most actionable submissions specify the page in question, the exact passage being corrected, and a supporting reference — a DOI or PubMed identifier where possible — so a proposed change can be verified against its source before it is acted on.

Editorial mailbox: editors@southernpeptideco.com

What this desk cannot do

A logbook is not a clinical service and Southern Peptide Co is no vendor, so some requests fall outside it: it cannot green-light or steer anyone's use of these peptides, put a number on a dose or route for an individual, judge whether a cited finding fits a specific person, or sell, source, or help track down any compound. It also cannot counsel athletes under anti-doping testing, since two of the three compounds here are WADA-prohibited.

None of the compounds covered on this site is an approved systemic medicine. A clinician licensed where you live is the right person for a medical question. Editorial mail is read as time allows, and a reply is not guaranteed.